Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin 1A receptor (5-HT1A) is a subtype of serotonin receptors and a G protein-coupled receptor (GPCR) coupled to Gi/o proteins. It is widely expressed in the brain, particularly in the cerebral cortex, hippocampus, septum, amygdala, and raphe nucleus. Functioning as both an autoreceptor on serotonergic neurons in the raphe nuclei and as a postsynaptic heteroreceptor in target brain regions, it plays a key role in modulating mood, anxiety, cognition, and hormone secretion. Activation of the receptor leads to hyperpolarization and inhibition of neuronal firing, making it a therapeutic target for anxiety disorders and depression.
Activation of Gi/o proteins, inhibition of adenylyl cyclase, decrease in cAMP production, opening of potassium channels, hyperpolarization of neurons, inhibition of calcium channels, reduction of neurotransmitter release.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptor 5-HT1A (None).